| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.02 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.02 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.02 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |